A COVID-19 variant that has led to a resurgence in cases in China has now been discovered in the United States according to the U.S. Centers for Disease Control and Prevention. Reports say that a CDC ...

Pfizer PFE1.60%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...

Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral ...

Pfizer discontinues danuglipron after liver injury in trial patient Lilly and Novo Nordisk shares rise after Pfizer's decision Pfizer to focus on other obesity research April 14 (Reuters) - Pfizer ...

Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...

Pfizer posts mixed first-quarter results, maintains annual forecast COVID vaccine sales better-than-expected, while sales of antiviral treatment decline Expects to save $7.7 billion in costs by ...